Promethera Biosciences to Present at Several International Partnering and Scientific Conferences this Fall

 

Promethera Biosciences SA, a global innovator in cell-based medicines, today announced that the Company will give presentations at several upcoming scientific and partnering conferences in Asia, Europe and the US.

Including:

  • CTRMS 2017 - Cell Transplant and Regenerative Medicine Society Meeting
    Date: September 26-29, 2017
    Venue: Halifax, Nova Scotia, Canada
     
  • 16th Sachs Annual Biotech in Europe Forum
    Date: September 27-28, 2017
    Venue: Basel, Switzerland 

  • 2017 Cell & Gene Meeting on the Mesa
    Date: October 4-6, 2017
    Venue: La Jolla, CA, USA 

  • 59th Annual Meeting of the Japanese Society for Inherited Metabolic Disease
    Date: October 14, 2017
    Venue: Kawagoe, Japan 

  • 10th Annual Sofinnova Japan Biopharma Partnering Conference
    Date: October 24, 2017
    Venue: Tokyo, Japan 

  • BIO-Europe 2017 - 23rd Annual International Partnering Conference
    Date: November 6-8, 2017
    Venue: Berlin, Germany

Note

About Promethera Biosciences

Promethera Biosciences is a global innovator in liver cell-based medicines whose mission is to help patients overcome acute and chronic liver diseases. Our lead clinical program, derived from our patented cell technology platform HepaStem, is designed to benefit from its immune-modulatory and anti-fibrotic properties. We are a team of international experts operating out of R&D and GMP facilities in Mont-Saint-Guibert, Belgium, and Durham, NC, USA.

Promethera®, HepaStem®, H2stem®, Cytonet®, Heparesc® are all registered trademarks of the PROMETHERA group.

 

 

Interested in a regular update of the Life Sciences and biotech sector in Flanders?